Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $1.15 billion. The enterprise value is $919.46 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 273.92 million shares outstanding. The number of shares has increased by 26.22% in one year.
| Current Share Class | 273.92M |
| Shares Outstanding | 273.92M |
| Shares Change (YoY) | +26.22% |
| Shares Change (QoQ) | +18.56% |
| Owned by Insiders (%) | 10.60% |
| Owned by Institutions (%) | 71.93% |
| Float | 175.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 197.54 |
| Forward PS | 186.53 |
| PB Ratio | 5.24 |
| P/TBV Ratio | 5.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 145.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.48, with a Debt / Equity ratio of 0.32.
| Current Ratio | 10.48 |
| Quick Ratio | 10.39 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,399.04 |
Financial Efficiency
Return on equity (ROE) is -64.93% and return on invested capital (ROIC) is -29.02%.
| Return on Equity (ROE) | -64.93% |
| Return on Assets (ROA) | -25.70% |
| Return on Invested Capital (ROIC) | -29.02% |
| Return on Capital Employed (ROCE) | -35.47% |
| Revenue Per Employee | $86,438 |
| Profits Per Employee | -$1.37M |
| Employee Count | 73 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.46% in the last 52 weeks. The beta is 1.03, so TSHA's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +108.46% |
| 50-Day Moving Average | 4.19 |
| 200-Day Moving Average | 2.75 |
| Relative Strength Index (RSI) | 48.38 |
| Average Volume (20 Days) | 3,691,765 |
Short Selling Information
The latest short interest is 44.37 million, so 16.20% of the outstanding shares have been sold short.
| Short Interest | 44.37M |
| Short Previous Month | 41.98M |
| Short % of Shares Out | 16.20% |
| Short % of Float | 25.32% |
| Short Ratio (days to cover) | 4.37 |
Income Statement
In the last 12 months, TSHA had revenue of $6.31 million and -$99.93 million in losses. Loss per share was -$0.34.
| Revenue | 6.31M |
| Gross Profit | 6.31M |
| Operating Income | -102.13M |
| Pretax Income | -99.93M |
| Net Income | -99.93M |
| EBITDA | -100.98M |
| EBIT | -102.13M |
| Loss Per Share | -$0.34 |
Full Income Statement Balance Sheet
The company has $297.34 million in cash and $69.08 million in debt, giving a net cash position of $228.26 million or $0.83 per share.
| Cash & Cash Equivalents | 297.34M |
| Total Debt | 69.08M |
| Net Cash | 228.26M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 218.99M |
| Book Value Per Share | 0.80 |
| Working Capital | 271.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$84.68 million and capital expenditures -$486,000, giving a free cash flow of -$85.16 million.
| Operating Cash Flow | -84.68M |
| Capital Expenditures | -486,000 |
| Free Cash Flow | -85.16M |
| FCF Per Share | -$0.31 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,618.54% |
| Pretax Margin | -1,583.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.22% |
| Shareholder Yield | -26.22% |
| Earnings Yield | -8.71% |
| FCF Yield | -7.42% |
Analyst Forecast
The average price target for TSHA is $10.22, which is 143.91% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.22 |
| Price Target Difference | 143.91% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 126.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of -0.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.06 |
| Piotroski F-Score | 2 |